{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:18:25Z","timestamp":1793092705909,"version":"4.5.0"},"reference-count":183,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jvoice.2021.10.001","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T04:10:59Z","timestamp":1651551059000},"page":"540.e13-540.e43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Treatment Outcome Measures for Spasmodic Dysphonia: A Systematic Review"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6542-4942","authenticated-orcid":false,"given":"Anna","family":"Rumbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Aiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3839-1353","authenticated-orcid":false,"given":"Daniel","family":"Novakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2021.10.001_bib0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0021-9924(00)00039-3","article-title":"Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges","volume":"34","author":"Barkmeier","year":"2001","journal-title":"J Comm Dis"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0002","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00005537-199810000-00003","article-title":"Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients","volume":"108","author":"Blitzer","year":"1998","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0003","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archotol.130.4.415","article-title":"Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia","volume":"130","author":"Rubin","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0004","unstructured":"National Spasmodic Dysphonia Association, Spasmodic dysphonia. Available from: http:\/\/www.dysphonia.org\/spasmodic-dysphonia.php 2016. Accessed March 16 2017"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005537-200202000-00004","article-title":"Risk factors and demographics in patients with spasmodic dysphonia","volume":"112","author":"Schweinfurth","year":"2002","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0006","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0196-0709(84)80015-0","article-title":"Spastic dysphonia: a patient profile of 200 cases","volume":"5","author":"Izdebski","year":"1984","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0007","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jcomdis.2005.03.003","article-title":"The consequences of spasmodic dysphonia on communication-related quality of life: a qualitative study of the insider's experiences","volume":"38","author":"Baylor","year":"2005","journal-title":"J Comm Dos"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0008","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0892-1997(98)80042-8","article-title":"Spasmodic dysphonia and vocal fold paralysis: outcomes of voice problems on work-related functioning","volume":"12","author":"Smith","year":"1998","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0009","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1044\/jshd.4601.52","article-title":"Adductor spastic dysphonia as a sign of essential (voice tremor)","volume":"46","author":"Aronson","year":"1981","journal-title":"J Speech Hear Disord"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/000348948509400614","article-title":"Electromyographic findings in focal laryngeal dystonia (dysphonia)","volume":"94","author":"Blitzer","year":"1985","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0011","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1007\/s00415-015-7751-2","article-title":"Alcohol responsiveness in laryngeal dystonia: a survey study","volume":"262","author":"Kirke","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0012","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/lary.21395","article-title":"Botulinum toxin treatment of adductor spasmodic dysphonia: Longitudinal functional outcomes","volume":"121","author":"Novakovic","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0013","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1044\/1058-0360(2012\/12-0014)","article-title":"Evidence-based clinical voice assessment: a systematic review","volume":"22","author":"Roy","year":"2013","journal-title":"Am J Speech Lang Pathol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0014","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s004050000299","article-title":"A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques: guideline elaborated by the Committee of Phoniatrics of the","volume":"258","author":"Dejonckere","year":"2001","journal-title":"European Laryngological SOCIETY (ELS), Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0015","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-15-247","article-title":"Core outcome measures in effectiveness trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a \u2018core outcome set","volume":"15","author":"Prinsen","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0016","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1745-6215-13-132","article-title":"Developing core outcome sets for clinical trials: Issues to consider","volume":"13","author":"Williamson","year":"2012","journal-title":"Trials"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-016-1555-2","article-title":"How to select outcome measurement instruments for outcomes included in a \u201cCore Outcome Set\u201d \u2013 a practical guideline","volume":"17","author":"Prinsen","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0018","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0019","doi-asserted-by":"crossref","first-page":"158","DOI":"10.13181\/mji.v6i3.820","article-title":"Perceptual and acoustic assessments on spasmodic dysphonia: pre and post-botulinum toxin injection","volume":"6","author":"Abdoerrachman","year":"1997","journal-title":"Med J Indones"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00005537-199603000-00010","article-title":"Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia","volume":"106","author":"Adams","year":"1996","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0021","first-page":"171","article-title":"Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results","volume":"22","author":"Adams","year":"1993","journal-title":"J Otolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0022","first-page":"345","article-title":"Comparison on botulinum toxin injection procedures in adductor spasmodic dysphonia","volume":"24","author":"Adams","year":"1995","journal-title":"J Otolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0023","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/mds.20098","article-title":"Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia","volume":"19","author":"Adler","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0024","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1044\/1092-4388(2006\/081)","article-title":"Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: A H2150 PET study","volume":"49","author":"Ali","year":"2006","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2310\/7070.2003.40431","article-title":"Selective denervation: reinnervation for the control of adductor spasmodic dysphonia","volume":"32","author":"Allegretto","year":"2003","journal-title":"J Otolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0026","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1097\/MLG.0b013e3180de4d63","article-title":"Nonpharmacologic effects of botulinum toxin on the life quality of patients with spasmodic dysphonia","volume":"117","author":"Anari","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0027","first-page":"2","article-title":"Adductor spastic dysphonia: 1\u00bd years after recurrent laryngeal nerve resection","volume":"90","author":"Aronson","year":"1981","journal-title":"Ann Otol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1288\/00005537-198301000-00001","article-title":"Adductor spastic dysphonia: Three years after recurrent laryngeal nerve resection","volume":"93","author":"Aronson","year":"1983","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0029","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1288\/00005537-199306000-00019","article-title":"Botulinum toxin injection for adductor spastic dysphonia: Patient self-ratings of voice and phonatory effort after three successive injections","volume":"103","author":"Aronson","year":"1993","journal-title":"Laryngosope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1044\/1092-4388(2004\/003)","article-title":"Speech intelligibility in severe adductor spasmodic dysphonia","volume":"47","author":"Bender","year":"2004","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0031","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/archotol.127.9.1083","article-title":"Outcome of botulinum toxin treatment for patients with spasmodic dysphonia","volume":"127","author":"Benninger","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0032","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/000348949910800302","article-title":"Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia","volume":"108","author":"Berke","year":"1999","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0033","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/000348940111000503","article-title":"Assessment of posterior cricoarytenoid botulinum toxin injections in patients with abductor spasmodic dysphonia","volume":"100","author":"Bielamowicz","year":"2001","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0034","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/000348940010900215","article-title":"Effects of botulinum toxin of pathophysiological in spasmodic dysphonia","volume":"109","author":"Bielamowicz","year":"2000","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/000348949110000201","article-title":"Laryngeal dystonia: a series with botulinum toxin therapy","volume":"100","author":"Blitzer","year":"1991","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0036","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0892-1997(05)80035-9","article-title":"Treatment of spasmodic dysphonia (laryngeal dystonia) with local injections of botulinum toxin","volume":"6","author":"Blitzer","year":"1992","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0037","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1288\/00005537-199202000-00011","article-title":"Abductor laryngeal dystonia: a series treated with botulinum toxin","volume":"102","author":"Blitzer","year":"1992","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0038","first-page":"140","article-title":"Spasmodic dysphonia in an adolescent patient with an autoimmune neurologic disorder","volume":"28","author":"Boseley","year":"2007","journal-title":"Am J Otolaryngol Head Neck Med Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0039","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mds.870040401","article-title":"Adductor laryngeal dystonia (spastic dysphonia): Treatment with local injections of botulinum toxin (Botox)","volume":"4","author":"Brin","year":"1989","journal-title":"Mov Disord"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0040","first-page":"237","article-title":"Laryngeal dystonia (spasmodic dysphonia): Observations of 901 patients and treatment with botulinum toxin","volume":"78","author":"Brin","year":"1998","journal-title":"Dystonia 3Adv Neurol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0041","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jvoice.2004.07.001","article-title":"Spectral amplitude measures of adductor spasmodic dysphonic speech","volume":"19","author":"Cannito","year":"2005","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvoice.2012.05.005","article-title":"Perceptual structure of adductor spasmodic dysphonia and its acoustic correlates","volume":"26","author":"Cannito","year":"2012","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0043","first-page":"125","article-title":"Attitudes toward communication in adductor spasmodic dysphonia before and after botulinum toxin injection","volume":"2","author":"Cannito","year":"1994","journal-title":"J Med Speech Lang Pathol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0044","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/archotol.130.12.1393","article-title":"Perceptual analyses of spasmodic dysphonia before and after treatment","volume":"130","author":"Cannito","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.otohns.2005.10.028","article-title":"Botulinum toxin injection and airflow stability in spasmodic dysphonia","volume":"134","author":"Cantarella","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0046","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1097\/00005537-200409000-00019","article-title":"Long-term results of Type II thyroplasty for adductor spasmodic dysphonia","volume":"114","author":"Chan","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0047","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.otc.2005.10.005","article-title":"Treatment of adductor spasmodic dysphonia with selective laryngeal adductor denervation and reinnervation surgery","volume":"39","author":"Chhetri","year":"2006","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0048","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/000348940010900906","article-title":"Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin","volume":"109","author":"Courey","year":"2000","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0049","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0892-1997(97)80082-3","article-title":"Adductor spasmodic dysphonia: Case reports with acoustic analysis following botulinum toxin injection and acupuncture","volume":"11","author":"Crevier-Buchman","year":"1997","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jvoice.2000.11.001","article-title":"The impact of long-term botulinum toxin injections on symptom severity in patients with spasmodic dysphonia","volume":"18","author":"Damrose","year":"2004","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0051","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/000348949110000403","article-title":"Recurrent laryngeal nerve section for spastic dysphonia: 5- to 14-year preliminary results in the first 300 patients","volume":"100","author":"Dedo","year":"1991","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0052","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/000348948409300412","article-title":"Evaluation and treatment of recurrent spasticity after recurrent laryngeal nerve section: a preliminary report","volume":"93","author":"Dedo","year":"1984","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0053","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00405-011-1890-6","article-title":"Tridimensional assessment of adductor spasmodic dysphonia pre- and post-treatment with botulinum toxin","volume":"269","author":"Dejonckere","year":"2012","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0054","first-page":"263","article-title":"Lip kinematics in spasmodic dysphonia before and after treatment with botulinum toxin","volume":"15","author":"Dromey","year":"2007","journal-title":"J Med Speech Lang Pathol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0055","first-page":"3","article-title":"Anxiety associated with botox injections for adductor spasmodic dysphonia","volume":"21","author":"Epstein","year":"1996","journal-title":"Logopedica Phoniatrics Vocology"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0056","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/09638289709166441","article-title":"The short-term impact of botox injections on speech disability in adductor spasmodic dysphonia","volume":"19","author":"Epstein","year":"1997","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0057","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s10072-015-2239-5","article-title":"Spasmodic dysphonia follow-up with videolaryngoscopy and voice spectography during treatment with botulinum toxin","volume":"36","author":"Esposito","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0058","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00005537-199908000-00021","article-title":"Increased stability of airflow following botulinum toxin injection","volume":"109","author":"Finnegan","year":"1999","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0059","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1044\/jshr.3905.968","article-title":"Longitudinal phonatory characteristics after botulinum toxin type A injection","volume":"39","author":"Fisher","year":"1996","journal-title":"J Speech Hear Res"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0892-1997(99)80023-X","article-title":"Electroglottographic tracking of phonatory response to botox","volume":"13","author":"Fisher","year":"1999","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0061","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/019459989010300515","article-title":"Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia","volume":"103","author":"Ford","year":"1990","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0062","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0892-1997(05)80036-0","article-title":"Botulinum toxin treatment of spasmodic dysphonia: Techniques, indications, efficacy","volume":"6","author":"Ford","year":"1992","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0063","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000265645","article-title":"Experiences with recurrent laryngeal section for spastic dysphonia","volume":"34","author":"Fritzell","year":"1982","journal-title":"Folia Phoniat"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0064","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0892-1997(05)80348-0","article-title":"Long-term results of recurrent laryngeal nerve resection for adductor spasmodic dysphonia","volume":"7","author":"Fritzell","year":"1993","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0065","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1007\/s00405-014-3129-9","article-title":"Vocal outcome after endoscopic thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia","volume":"271","author":"Gandhi","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0066","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000449100","article-title":"Long-term follow-up of patients with spasmodic dysphonia and improved voice despite discontinuation of treatment","volume":"68","author":"Geneid","year":"2016","journal-title":"Folia Phoniatrica et Logopaedica"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0067","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/000348949210101101","article-title":"Point-touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia","volume":"101","author":"Green","year":"1992","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0068","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.baga.2013.08.002","article-title":"Correlation of self-assessment with expert rating and acoustic analysis for spasmodic dysphonia treatment with botulinum neurotoxin A","volume":"3","author":"Hartmann","year":"2013","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0069","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1212\/01.wnl.0000184478.59063.db","article-title":"Silent event-related\u201d fMRI reveals reduced sensorimotor activation in laryngeal dystonia","volume":"65","author":"Haslinger","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00998566","article-title":"Treatment of spastic dysphonia by EMG biofeedback","volume":"3","author":"Henschen","year":"1978","journal-title":"Biofeedback Self Regul"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0071","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0892-1997(01)00060-1","article-title":"Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia","volume":"15","author":"Hogikyan","year":"2001","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0072","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1017\/S0022215110000253","article-title":"Selective lateral laser thyroarytenoid myotomy for adductor spasmodic dysphonia","volume":"124","author":"Hussain","year":"1984","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0073","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/000348940010900214","article-title":"Midline lateralization thyroplasty for adductor spasmodic dysphonia","volume":"109","author":"Isshiki","year":"2000","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0074","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/019459988108900121","article-title":"Postoperative and follow-up studies of spastic dysphonia patients treated by recurrent laryngeal nerve section","volume":"89","author":"Izdebski","year":"1981","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0075","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00405-003-0604-0","article-title":"Spasmodic dysphonia combined with insufficient glottis closure by phonation","volume":"260","author":"Kaszas","year":"2003","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0076","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jvoice.2009.08.003","article-title":"Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor","volume":"25","author":"Kendall","year":"2011","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0077","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1749-4486.2008.01777.x","article-title":"Radiofrequency thyroarytenoid myothermy for treatment of adductor spasmodic dysphonia: how we do it","volume":"33","author":"Kim","year":"2008","journal-title":"Clinical Otolaryngology"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0078","article-title":"Treatment efficacy of electromyography versus fiberscopy-guided botulinum toxin injection in adductor spasmodic dysphonia patients: A prospective comparative study","volume":"327928","author":"Kim","year":"2014","journal-title":"Scientific World Journal"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0079","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.otohns.2008.06.013","article-title":"III. Vocal outcome measures after bilateral posterior cricoarytenoid muscle botulinum toxin injections for abductor spasmodic dysphonia","volume":"139","author":"Klein","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0080","first-page":"159","article-title":"Preliminary report: management of abductor spasmodic dysphonia by endoscopic partial posterior cricoarytenoid (PCA) myectomy","volume":"2","author":"Koufman","year":"1999","journal-title":"Phonoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0081","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/000348940611500203","article-title":"Treatment of adductor-type spasmodic dysphonia by surgical myectomy: a preliminary report","volume":"115","author":"Koufman","year":"2006","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0082","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/000348949810700403","article-title":"Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia","volume":"107","author":"Langeveld","year":"1998","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0083","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/000348940111001009","article-title":"Adductor spasmodic dysphonia and botulinum toxin treatment: The effect on well-being","volume":"110","author":"Langeveld","year":"2001","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0084","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/000348940111000707","article-title":"Evaluation of voice quality in adductor spasmodic dysphonia before and after botulinum toxin treatment","volume":"110","author":"Langeveld","year":"2001","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0085","first-page":"66","article-title":"Prospective study of patients\u2019 subjective responses to botulinum toxin injection for spasmodic dysphonia","volume":"25","author":"Liu","year":"1996","journal-title":"J Otolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0086","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0163-8343(98)00022-X","article-title":"Emotional symptoms are secondary to the voice disorder in patients with spasmodic dysphonia","volume":"20","author":"Liu","year":"1998","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0087","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/019459989010200205","article-title":"Spasmodic dysphonia: Botulinum toxin injection after recurrent nerve surgery","volume":"102","author":"Ludlow","year":"1990","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0088","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1212\/WNL.38.8.1220","article-title":"Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia","volume":"38","author":"Ludlow","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0089","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/019459989110400614","article-title":"Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injection","volume":"104","author":"Ludlow","year":"1991","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0090","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0892-1997(98)80055-6","article-title":"The effect of patient factors on response outcomes to botox treatment of spasmodic dysphonia","volume":"12","author":"Lundy","year":"1998","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0091","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/000348940411300502","article-title":"Tremor laryngeal dystonia: Treatment of the lateral cricoarytenoid muscle","volume":"113","author":"Maronian","year":"2004","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0092","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archotol.127.4.393","article-title":"Long-term therapy for spasmodic dysphonia: acoustic and aerodynamic outcomes","volume":"127","author":"Mehta","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0093","first-page":"31","article-title":"A stuttering therapy programme with spastic dysphonia \u2013 a single case study","volume":"32","author":"Meyers","year":"1985","journal-title":"S Afr J Commun Disord"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0094","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archotol.1987.01860060029009","article-title":"Botulinum toxin injection of the vocal fold for spasmodic dysphonia","volume":"113","author":"Miller","year":"1987","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0095","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1017\/S0022215111000739","article-title":"The point-touch technique for botulinum toxin injection in adductor spasmodic dysphonia: quality of life assessment","volume":"125","author":"Morzaria","year":"2011","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0096","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jvoice.2010.07.011","article-title":"A comparison of the VHI, VHI-10, V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia","volume":"26","author":"Morzaria","year":"2012","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0097","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/archotol.1994.01880270056010","article-title":"Spasmodic dysphonia: Emotional status and botulinum toxin treatment","volume":"120","author":"Murry","year":"1994","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0098","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0892-1997(05)80211-5","article-title":"Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy","volume":"9","author":"Murry","year":"1995","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0099","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1080\/00016480801965019","article-title":"Surgical treatment for adductor spasmodic dysphonia \u2013 efficacy of bilateral thyroarytenoid myectomy under microlaryngoscopy","volume":"128","author":"Nakamura","year":"2008","journal-title":"Acta Oto-Laryngologica"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0100","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jvoice.2014.09.030","article-title":"The comparison of thyroarytenoid muscle myectomy and type II thyroplasty for spasmodic dysphonia","volume":"29","author":"Nomoto","year":"2015","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0101","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/MLG.0b013e31815e8be0","article-title":"Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life results","volume":"118","author":"Paniello","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0102","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/000348940911801102","article-title":"Vocal exercises versus voice rest following botulinum toxin injections: a randomized crossover trial","volume":"118","author":"Paniello","year":"2009","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0103","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00405-004-0897-7","article-title":"Bipolar radiofrequency-induced thermotherapy (rfitt) for the treatment of spasmodic dysphonia. A report of three cases","volume":"262","author":"Remacle","year":"2005","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0104","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/019459989411100615","article-title":"Technique for injection of botulinum toxin through the flexible nasolaryngoscope","volume":"111","author":"Rhew","year":"1994","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvoice.2016.09.029","article-title":"Vocal parameters and self-perception in individuals with adductor spasmodic dysphonia","volume":"31","author":"Rojas","year":"2017","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0106","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1288\/00005537-199108000-00019","article-title":"A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report","volume":"101","author":"Rontal","year":"1991","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0107","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archotol.130.4.415","article-title":"Longitudinal effects of botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: Part II","volume":"130","author":"Rubin","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0108","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/lary.26381","article-title":"An open-label study of sodium oxybate in spasmodic dysphonia","volume":"127","author":"Rumbach","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0109","first-page":"67","article-title":"Longitudinal study of temporal speech alterations in an individual with adductor spasmodic dysphonia treated with botulinum toxin","volume":"15","author":"Salvatore","year":"2007","journal-title":"J Med Speech Lang Pathol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0110","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1097\/MLG.0b013e31814684fa","article-title":"Overall evaluation of effectiveness of type II thyroplasty for adductor spasmodic dysphonia","volume":"117","author":"Sanuki","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0111","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.anl.2013.11.001","article-title":"Long-term Voice Handicap Index after type II thyroplasty using titanium bridges for adductor spasmodic dysphonia","volume":"41","author":"Sanuki","year":"2014","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0112","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.otohns.2009.12.018","article-title":"Effects of type II thyroplasty on adductor spasmodic dysphonia","volume":"142","author":"Sanuki","year":"2010","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0113","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1044\/1092-4388(2002\/067)","article-title":"Acoustic variations in reading produced by speakers with spasmodic dysphonia pre-botox injection and within early stages of post-botox injection","volume":"45","author":"Sapienza","year":"2002","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0114","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00005537-199801000-00011","article-title":"Supraglottal injection of botulinum toxin type A in adductor type spasmodic dysphonia with both intrinsic and extrinsic hyperfunction","volume":"108","author":"Schonweiler","year":"1998","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/000348940311200403","article-title":"Posterior cricoarytenoid myoplasty with medialization thyroplasty in the management of refractory abductor spasmodic dysphonia","volume":"112","author":"Shaw","year":"2003","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0116","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jvoice.2010.08.004","article-title":"Combined modality treatment of adductor spasmodic dysphonia","volume":"26","author":"Silverman","year":"2012","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0117","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5334\/tohm.156","article-title":"Long-term effect of sodium oxybate (Xyrem\u00ae) in spasmodic dysphonia with vocal tremor","volume":"3","author":"Simonyan","year":"2013","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0118","first-page":"2077","article-title":"Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital","volume":"89","author":"Srirompotong","year":"2006","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0119","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/000348940711600103","article-title":"Transoral approach to laser thyroarytenoid myoneurectomy for treatment of adductor spasmodic dysphonia: short-term results","volume":"116","author":"Su","year":"2007","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/lary.20714","article-title":"Transoral laser ventricular fold resection and thyroarytenoid myoneurectomy for adductor spasmodic dysphonia: long-term outcome","volume":"120","author":"Su","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0121","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/000348940311200603","article-title":"Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section","volume":"112","author":"Sulica","year":"2003","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0122","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0967-5868(03)00020-1","article-title":"Spasmodic dysphonia: clinical features and effects of botulinum toxin therapy in 169 patients- An Australian experience","volume":"10","author":"Tisch","year":"2003","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0123","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1288\/00005537-199106000-00010","article-title":"Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia","volume":"101","author":"Truong","year":"1991","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0124","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1590\/S0034-72992006000200019","article-title":"Impact in vocal quality in partial myectomy and neurectomy endoscopic of thyroarytenoid muscle in patients with adductor spasmodic dysphonia","volume":"72","author":"Tsuji","year":"2006","journal-title":"Rev Bras Otorrinolaringol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvoice.2011.07.009","article-title":"Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality","volume":"26","author":"Tsuji","year":"2012","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0126","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1258\/0022215053561594","article-title":"Autologous replacement of the vocal fold: a new surgical approach for adduction-type spasmodic dysphonia","volume":"119","author":"Tsunoda","year":"2005","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0127","first-page":"1","article-title":"Botulinum toxin management of adductor spasmodic dysphonia with vocal tremors","volume":"12","author":"Wang","year":"2004","journal-title":"J Med Speech Lang Path"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0128","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jnnp.56.5.526","article-title":"The use of botulinum toxin in the treatment of adductor spasmodic dysphonia","volume":"56","author":"Whurr","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0129","first-page":"81","article-title":"Psychological function in spasmodic dysphonia before and after treatment with botulinum toxin","volume":"6","author":"Whurr","year":"1998","journal-title":"J Med Speech Lang Path"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1044\/jshd.4501.112","article-title":"Recurrent laryngeal nerve dissection: a case report involving return of spastic dysphonia after initial surgery","volume":"45","author":"Wilson","year":"1980","journal-title":"J Speech Hear Disord"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0131","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jvoice.2004.03.006","article-title":"Voice Handicap Index results for older patients with adductor spasmodic dysphonia","volume":"19","author":"Wingate","year":"2005","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0132","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1288\/00005537-199401000-00003","article-title":"Measurement of laryngeal resistance in the evaluation of botulinum toxin injection for treatment of focal laryngeal dystonia","volume":"104","author":"Witsell","year":"1994","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0133","first-page":"64","article-title":"Laryngeal image analysis following botulinum toxin injections in spasmodic dysphonia","volume":"24","author":"Wong","year":"1995","journal-title":"J Otolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0134","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0892-1997(05)80031-1","article-title":"Analysis of spasmodic dysphonia by aerodynamic and laryngostroboscopic measurements","volume":"6","author":"Woo","year":"1992","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0892-1997(05)80168-7","article-title":"Use of flexible fiberoptic laryngoscopy to assess patients with spasmodic dysphonia","volume":"5","author":"Woodson","year":"1991","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0136","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1097\/MLG.0b013e318124a97b","article-title":"Management of supraglottic squeeze in adductor spasmodic dysphonia: a new technique","volume":"117","author":"Young","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0137","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0892-1997(05)80167-5","article-title":"Acoustic changes in spasmodic dysphonia after botulinum toxin injection","volume":"5","author":"Zwirner","year":"1991","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0138","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1288\/00005537-199204000-00006","article-title":"Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings","volume":"102","author":"Zwirner","year":"1992","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0139","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0892-1997(05)80347-9","article-title":"Perceptual-acoustic relationships in spasmodic dysphonia","volume":"7","author":"Zwirner","year":"1993","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00186224","article-title":"A comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia","volume":"250","author":"Zwirner","year":"1993","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0141","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF01642557","article-title":"Effects of botulinum toxin on vocal tract steadiness in patients with spasmodic dysphonia","volume":"254","author":"Zwirner","year":"1997","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0142","series-title":"World Health Organization: International Classification of Functioning","year":"2001"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0143","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatr"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0144","series-title":"Voice problems of children","author":"Wilson","year":"1987"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0145","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-suicide severity rating scale: initial validity and internal consistency findings from three multiside studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0146","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1192\/bjp.112.490.917","article-title":"A short clinical diagnostic self-rating scale for psychoneurotic patients","volume":"112","author":"Crown","year":"1966","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0147","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0148","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1044\/jshr.1204.711","article-title":"Assessing communication attitudes among stutterers","volume":"12","author":"Erickson","year":"1969","journal-title":"J Speech Hear Res"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0149","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archotol.131.11.961","article-title":"Validity and reliability of the glottal function index","volume":"131","author":"Bach","year":"2005","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-3999(91)90011-C","article-title":"A scale for assessing quality of life in adult asthma sufferers","volume":"35","author":"Hyland","year":"1991","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0151","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety state by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psyc"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0152","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bs.3830190102","article-title":"The Hopkins symptom checklist (HSCL): a self-report symptom inventory","volume":"19","author":"Derogatis","year":"1974","journal-title":"Behav Sci"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0154","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasereddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0156","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1037\/h0040902","article-title":"An analysis of mood in neurotics","volume":"69","author":"McNair","year":"1964","journal-title":"J Abnorm Soc Psychol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0157","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J Health Soc Behav"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0158","series-title":"The measurement of depression","author":"Zung","year":"1965"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0159","series-title":"SF-36 Health Survey manual and interpretation guide","author":"Ware","year":"1993"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0021-9924(91)90006-5","article-title":"Emotional considerations in spasmodic dysphonia: psychometric quantification","volume":"24","author":"Cannito","year":"1991","journal-title":"J Comm Dis"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0161","series-title":"Manual for the State-Trait Anxiety Inventory (Form Y Self-Evaluation Questionnaire)","author":"Spielberger","year":"1983"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0162","first-page":"13","article-title":"SCL-90: An outpatient psychiatric rating scale \u2013 preliminary report","volume":"9","author":"Derogatis","year":"1973","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0163","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1044\/1092-4388(2001\/040)","article-title":"Voice activity and participation profile: assessing the impact of voice disorders on daily activities","volume":"44","author":"Ma","year":"2001","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0164","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1044\/1058-0360.0603.66","article-title":"The Voice Handicap Index (VHI): development and validation","volume":"6","author":"Jacobson","year":"1997","journal-title":"Am J Speech Lang Pathol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0165","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/00005537-200409000-00009","article-title":"Development and validation of the voice handicap index-10","volume":"114","author":"Rosen","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0166","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0892-1997(99)80010-1","article-title":"Validation of an instrument to measure voice-related quality of life (VRQOL)","volume":"13","author":"Hogikyan","year":"1999","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0167","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2007-986527","article-title":"Application of the ICF in reduced speech intelligibility in dysarthria","volume":"28","author":"Dykstra","year":"2007","journal-title":"Semin Speech Lang"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0168","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0892-1997(97)80029-X","article-title":"Adductor spasmodic dysphonia: standard evaluation of symptoms and severity","volume":"11","author":"Stewart","year":"1997","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0169","series-title":"Clinical examination of voice","author":"Hirano","year":"1981"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0170","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00405-005-1033-z","article-title":"The INFVo perceptual rating scale for substitution voicing: development and reliability","volume":"263","author":"Moerman","year":"2006","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0171","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.otohns.2008.05.624","article-title":"Research priorities in spasmodic dysphonia","volume":"139","author":"Ludlow","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0172","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00405-009-0995-7","article-title":"Spasmodic dysphonia, perceptual and acoustic analysis: presenting new diagnostic tools","volume":"266","author":"Siemons-Luhring","year":"2009","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0173","series-title":"Clinical voice disorders: an interdisciplinary approach","author":"Aronson","year":"1990"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0174","unstructured":"PCORI Methodology Committee. The PCORI (Patient-Centred Outcomes Research Institute) methodology report. 2013. Available from:www.pcori.org\/research-we-support\/research-methodology-standards. Accessed March 16 2017."},{"key":"10.1016\/j.jvoice.2021.10.001_bib0175","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1044\/1092-4388(2002\/037)","article-title":"Botox treatment in adductor spasmodic dysphonia: a meta-analysis","volume":"45","author":"Boutsen","year":"2002","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0176","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0892-1997(01)00038-8","article-title":"Acoustic measures of symptoms in abductor spasmodic dysphonia","volume":"15","author":"Edgar","year":"2001","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0177","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jvoice.2006.01.007","article-title":"The psychosocial consequences of BOTOX Injections for spasmodic dysphonia: a qualitative study of patients\u2019 experiences","volume":"21","author":"Baylor","year":"2007","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0178","first-page":"238","volume":"156","author":"van Esch","year":"2017"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0179","doi-asserted-by":"crossref","unstructured":"Wallace S.J.. Improving research outcome measurement in aphasia: Development of a core outcome set. PhD Thesis, School of Health and Rehabilitation Sciences, The University of Queensland. https:\/\/doi.org\/10.14264\/uql.2017.61","DOI":"10.14264\/uql.2017.61"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0180","first-page":"1","article-title":"Which outcomes are most important to people with aphasia and their families? An international nominal group technique study framed within the ICF","volume":"39","author":"Wallace","year":"2016","journal-title":"Disability and Rehabilitation"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0181","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/02687038.2016.1186265","article-title":"Which treatment outcomes are most important to aphasia clinicians and managers? An international e-Delphi consensus study","volume":"31","author":"Wallace","year":"2017","journal-title":"Aphasiology"},{"key":"10.1016\/j.jvoice.2021.10.001_bib0182","doi-asserted-by":"crossref","first-page":"S729","DOI":"10.1044\/2016_AJSLP-15-0150","article-title":"Core outcomes in aphasia treatment research: an e-Delphi consensus study of international aphasia researchers","volume":"25","author":"Wallace","year":"2016","journal-title":"Am J Speech Lang Pathol"},{"key":"10.1016\/j.jvoice.2021.10.001_bib183","first-page":"1","article-title":"Many ways of measuring: a scoping review of measurement instruments for use with people with aphasia","author":"Wallace","year":"2020","journal-title":"Aphasiology"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089219972100326X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089219972100326X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T12:49:14Z","timestamp":1711630154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089219972100326X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":183,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S089219972100326X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2021.10.001","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Outcome Measures for Spasmodic Dysphonia: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2021.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Inc. on behalf of The Voice Foundation. All rights reserved.","name":"copyright","label":"Copyright"}]}}